Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zepatier
Pharma
FDA flags liver risks for AbbVie, Merck, Gilead hep C meds
The FDA is tracking rare cases of liver damage and even death, mostly in patients who shouldn't have been taking the drugs in the first place.
Eric Sagonowsky
Aug 29, 2019 10:45am
Keytruda sales stoke Merck's Q1, but where's the future growth?
May 1, 2018 11:28am
The #FierceMadness Final Four is set
Mar 28, 2018 9:00am
Gilead wins reversal of $2.54B verdict in Merck hep C case
Feb 20, 2018 9:53am
Merck to high-risk military veterans: Get a hep C education
Oct 16, 2017 9:15am
Gilead nabs Chinese nod for Sovaldi, eyeing a 10M hep C base
Sep 25, 2017 12:00pm
